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MethodsIntroduction
Infections are a frequent and possibly life-threatening problem in intensive
care unit patients, and antibiotic therapy is one of the cornerstones of the
treatment.
Therapeutic drug monitoring has been proposed to optimise antibiotic therapy
but measuring tissue concentrations remains difficult (1).
The ExaBreath® device (SensAbues AB, Sollentuna, Sweden, Fig. 1) has
proven reliable for collecting exhaled breath to detect recreational drugs but
has not been evaluated for measuring antibiotic concentrations (2,3).
AIMS:
To explore the feasibility and safety of the ExaBreath®-device to determine
antibiotic concentrations in exhaled air.
Eleven spontaneously breathing patients treated with piperacillin/tazobactam
or meropenem and considered capable of exhaling for 3 minutes through the
ExaBreath®-device participated.
Patients exhaled through the device until the control container was full (which
equates to 30L of exhaled breath), or until the patient wanted to stop.
Samples were analyzed using liquid chromato-graphy high resolution mass
spectrometry. The devices were opened and the filters were extracted with 2
mL 70:30 4% NaCl in water:isopropanol containing piperacillin-D5 and
meropenem-D6 as internal standards. A 3D printed spacer was used for
centrifugation (Fig. 2) The analysis was performed by liquid chromatography
high-resolution mass spectrometry on a Thermo Q-Exactive.
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Figure 1. The sampling method with the ExaBreath® device
Results
Nine patients (7 men, 2 women) were treated with piperacillin/tazobactam, 2
(men) with meropenem.
Seven out of 11 patients were able to exhale in a standardized way in the
device. The remaining 4 did not exhale correctly, became tired or the control
container filled too slowly.
No complications directly related to the procedure occurred.
Antibiotic concentrations were detectable in exhaled breath. Measured
concentration were between 5.54pg and 1253pg/filter.
No correlation between the piperacillin concentration in the exhaled breath
and plasma was found.
A positive correlation between piperacillin concentration in exhaled breath and
breath condensate was found.
Discussion
This pilot trial confirmed that it is possible to use the ExaBreath®-device in
critically ill patients, although there were some practical difficulties in exhaling
in a coordinated way in 4 out of 11 patients.
Further research is necessary to evaluate the potential use of the
ExaBreath®-device in the treatment of infections in the ICU. Sampling
patients on mechanically ventilated patients could bypass the difficulties in
exhaling in a non-standardized way.
Figure 2. Extraction method for antibiotics in electret filter which is used for exhaled 
breath sampling.
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